Pregnancy: Pregabalin: Pregnancy Category C. There are no adequate and well-controlled studies in pregnant women. Pregabalin should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.
Mecobalamin: Mecobalamin crosses the placenta. Supplementation with mecobalamin may improve the nutritional status of pregnancy women. However, data from clinical trials are inadequate. Pregnant women should only use higher doses if it is recommended by the physician.
Women of childbearing potential: Pregabalin: As the potential risk for humans is unknown, effective contraception must be used in women of childbearing potential.
Mecobalamin: No maternal or fetal complications have been associated with the use of vitamin B12.
Labor and Delivery: The effects of pregabalin on labor and delivery in pregnant women are unknown.
Lactation: Pregabalin: Pregabalin is excreted in the milk of breastfeeding women. As the safety of pregabalin in infants is not known, breastfeeding is not recommended in women taking pregabalin. A decision should be made whether to discontinue breastfeeding or to discontinue pregabalin therapy, taking into consideration the benefit of breastfeeding for the child and the benefit of therapy for the mother. Patients should be advised to notify their physician if they are breastfeeding.
Mecobalamin: Mecobalamin appears in breast milk. It is compatible with lactation at usual dosages.
Other Services
Country
Account